Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
The Journal of Infection|November 26, 2013
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapyAntonio Rivero-Juarez, Karin Neukam, Pablo Labarga, et al.The Journal of Infectious Diseases|August 4, 2007
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patientsPablo Labarga, Vicente Soriano, Maria Eugenia Vispo, et al.Journal of Virology|April 23, 2002
Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteinsPablo Sarobe, Juan José Lasarte, Noelia Casares, et al.AIDS (London, England)|June 17, 2004
Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary resultsPere Domingo, Pablo Labarga, Rosario Palacios, et al.AIDS (London, England)|March 19, 2014
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapyEugenia Vispo, Pablo Barreiro, Zulema Plaza, et al.AIDS (London, England)|March 20, 2010
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrationsSonia Rodríguez-Nóvoa, Pablo Labarga, Antonio D'avolio, et al.Antiviral Therapy|September 14, 2010
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapyPaula Tuma, Jose Medrano, Salvador Resino, et al.Antiviral Therapy|June 21, 2011
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in SpainPaula Tuma, Juan Antonio Pineda, Pablo Labarga, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic studySonia Rodríguez-Nóvoa, Pablo Labarga, Vincent Soriano, et al.AIDS Research and Human Retroviruses|September 16, 2008
HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionalityMariola López, Norma Rallón, Vincent Soriano, et al.Pageof 11